Inventor · disambiguated record
Ann Marie Pendergast
Also filed as: PENDERGAST ANN MARIE
8 granted patents·2 pending applications·17 citations·filing 1994–2023
82Inventor score
Top patents by PatentIndex Score
10 records- 0183US11883401B2Compositions for the treatment of pathogenic- and/or chemical-induced lung injury and for the treatment of cancer and methods of using sameUNIV DUKE·Filed 2020·Granted Jan 30, 2024·2 cites·10 claims
- 0276US9931342B2Compositions and methods for the treatment of cancerUNIV DUKE·Filed 2017·Granted Apr 3, 2018·1 cites·52 claims
- 0375US12419891B2Compositions for the treatment of pathogenic- and/or chemical-induced lung injury and for the treatment of cancer and methods of using sameUNIV DUKE·Filed 2023·Granted Sep 23, 2025·0 cites·20 claims
- 0457US2003092079A1Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactionsNEW YORK UNIVERSITY DUKE UNIVE·Filed 2002·Application pending·0 cites
- 0556US2024058335A1Methods for treatment of cancer using abl inhibitors and drugs targeting the mevalonate pathwayUNIV DUKE·Filed 2022·Application pending·0 cites
- 0653US7384907B2Method of treating infection with ABl tyrosine kinase inhibitorsUNIV DUKE·Filed 2003·Granted Jun 10, 2008·1 cites·18 claims
- 0743US5969101AABL-interactor proteinUNIV DUKE·Filed 1995·Granted Oct 19, 1999·4 cites·13 claims
- 0839US6255074B1Abl-interactor proteinUNIV DUKE·Filed 1996·Granted Jul 3, 2001·3 cites·21 claims
- 0934US6528270B1Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactionsSUGEN INC·Filed 1999·Granted Mar 4, 2003·3 cites·8 claims
- 1032US6066463AMethod and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disordersUNIV NEW YORK·Filed 1994·Granted May 23, 2000·3 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Ann Marie Pendergast files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →